The molecular targets of diclofenac differs from ibuprofen to induce apoptosis and epithelial mesenchymal transition due to alternation on oxidative stress management p53 independently in PC3 prostate cancer cells


Arisan E. D., Akar R. O., Rencuzogullari O., Yerlikaya P. O., Gurkan A., Akin B., ...Daha Fazla

PROSTATE INTERNATIONAL, cilt.7, sa.4, ss.156-165, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 7 Sayı: 4
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1016/j.prnil.2019.09.003
  • Dergi Adı: PROSTATE INTERNATIONAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.156-165
  • Anahtar Kelimeler: Apoptosis, Diclofenac, Epithelial mesenchymal transition, Ibuprofen, Nonsteroidal antiinflammatory drugs, Prostate cancer, Reactive oxygen species, SIGNALING PATHWAY, BETA-CATENIN, CYCLOOXYGENASE-2, CELECOXIB, EXPRESSION, INHIBITOR, INFLAMMATION, DYSFUNCTION, ACTIVATION, FOXO
  • Marmara Üniversitesi Adresli: Hayır

Özet

Background: Prostate cancer is the most common type of cancer among men. Studies showed that the regular use of nonsteroidal antiinflammatory drugs might reduce disease progression risk for prostate cancer patients with prostate cancer. We evaluated the effects of ectopic expression of p53 on the biological functions of ibuprofen and diclofenac.